I definitely don't disagree with your comments. I, for one, can't really speak to the S-1 filing or amendment as I'm not "savy" on understanding their meaning despite trying to read through them.
I'm an email administrator who, like many, bought in because of Tiger initially and have managed to average down and hold long in hopes of tangible growth.
There seem to be so many variables in play and of course we're talking about an OTC. Not to mention the many opinions, which I love hearing and reading daily but without substantiated fact they are simply conjecture.
I remain optimistic on long term ideas of the business plan execution but I'm certainly not unaware of the risks involved here.
I could have easily sold on pops and bought on dips along the way and be playing with house money but I didn't and I've learned a lot along the way.
Thanks for all the input as always.
Market Data 
Markets 
AI
